Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details
Silver Sponsor and exhibitor, Modality Solutions, joins a “who’s who” of pharmaceutical decision makers at the Executive Platform’s Biomanufacturing World Summit (BMWS18) in San Diego on October 29-30.
The BMWS18 brings together pharmaceutical executives, cutting-edge technology providers and media partners for its North America premier biologics event. President Gary Hutchinson and Principal Daniel Littlefield will attend the conference and participate in one-to-one meetings with other leaders in biopharmaceutical manufacturing and cold chain management.
BMWS18 participants learn about and discuss:
• Industry challenges and opportunities
• Quality as a culture, QbD, ICH guidelines
• Capacity management
• Supply chain management
• New processes and technologies
• Working with external partner
Modality Solutions is committed to helping biopharmaceutical companies explore cost-reduction strategies, understand changing industry standards, and initiate risk management processes to ensure compliance, quality and product integrity.
Click here to view the Modality Solutions BMWS18 press release.
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read DetailsCongratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic...
read DetailsCongratulations to Amicus Therapeutics for their European Commission approval for Pombiliti™ in patients with Late-Onset...
read Details